Hepatitis C virus seroprevalence and genotypes in patients with systemic lupus erythematosus (SLE) in Goiânia, Brazil;Soroprevalência e genótipos do vírus da hepatite C em pacientes com lúpus eritematoso sistêmico (LES) em Goiânia, Brasil

Revista Brasileira de Reumatologia

Volumn 45, Issue 4, 2005, Pages 201-205

  De Souza Barbosa, Vitalina ^a   Da Silva, Nílzio Antônio ^b   Bringel Martins, Regina Maria ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c IPTSP/UFG   (Brazil)

Author keywords

Hepatitis C virus; Rheumatic disease; Systemic lupus erythematosus (SLE)

Indexed keywords

HEPATITIS C ANTIBODY; RNA;

ARTICLE; BLOOD SAMPLING; BRAZIL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PREVALENCE; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33645582803     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lauer GM, Walker BD: Hepatitis C Virus Infection. N Engl J Med 345: 41-52, 2001.
2. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 15: 101-9, 1995.
3. Hadziyannis SJ: The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 4: 9-28, 1997.
4. McMurray RW: Hepatitis C-associated autoimmune disorders. Rheum Dis Clin North Am 24: 353-74, 1998.
5. Cacoub P, Poynard T, Ghillani P, et al: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42: 2204-12, 1999.
6. Cheney CP, Chopra S, Graham C: Hepatitis C. Infect Dis Clin North Am 14: 633-67, 2000.
7. Rivera J, García-Monforte A, Núñez-CortÉs JM: Extrahepatic symptoms as presenting manifestations of hepatitis C virus infection. J Clin Rheumatol 5: 268-72, 1999.
8. Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM: Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 94: 1355-60, 1999.
9. Lamprecht P, Gause A, Gross WL: Cryoglobulinemic vasculitis. Arthritis Rheum 42: 2507-16, 1999.
10. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L: Cryoglobulinemia vasculitis. Curr Opin Rheumatol 14: 29-35, 2002.
11. Lovy MR, Starkebaum G, Uberoi S: Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 23: 979-83, 1996.
12. Taglione E, Vatteroni ML, Martini P, et al: Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 26: 370-2, 1999.
13. Maillefert JF, Muller G, Falgarone G, et al: Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 61: 635-7, 2000.
14. Jorgensen C, Legouffe MC, Perney P, et al: Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 39: 1166-71, 1996.
15. Neto JG, Barone AA, Yoshinari N: Síndrome de Sjögren e infecção pelo vírus da hepatite C. Rev Hosp Clín Fac Med São Paulo 52: 101-3, 1997.
16. Garcia-Carrasco M, Ramos M, Cervera R, et al: Hepatitis C virus infection in 'primary' Sjogren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 56: 173-5, 1997.
17. Daoud MS, Gibson LE, Daoud S, el-Azhary RA: Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc 70: 559-64, 1995.
18. Valente RM, Hall S, O'Duffy JD, Conn DL: Vasculitis and related disorders. IN: Kelley WN, Harris ED, Ruddy S and Sledge CB. Textbook of Rheumatology, 5th ed, Philadelphia, WB Saunders: 1997, 1079-122.
19. Burstein DM, Rodby RA: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 4: 1288-93, 1993.
20. Lonzetti LT, Dalforno C, Von Muhler CA: Há associação entre vírus da hepatite C e fenômeno de Raynaud? Rev Bras Reumatol 37: 138-42, 1997.
21. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M: Symptomatic myopathy associated with Interferon therapy for chronic hepatitis C. Lancet 345(8949): 582, 1995.
22. Nishikai M, Miyairi M, Kosaka S: Dermatomyositis following infection with hepatitis C virus. J Rheumatol 21: 1584-5, 1994.
23. Clifford BD, Donahue D, Smith L, et al: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21: 613-9, 1995.
24. Prieto J, Yuste JR, Beloqui O, et al: Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 23: 199-204, 1996.
25. Wener MH, Johnson RJ, Sasso EH, Gretch DR: Hepatitis C virus and rheumatic disease. J Rheumatol 23: 953-9, 1996.
26. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D: Hepatitis B and C viruses serology in patients with SLE. Lupus 6: 543-4, 1997.
27. Ramos-Casals M, Font J, Garcia-Carrasco M, et al: Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 43: S251, 2000.
28. Schenatto CB, Silveira IG, Antonini ER: Prevalência do vírus da hepatite C em pacientes com doenças difusas do tecido conjuntivo. Rev Bras Reumatol 38: S55, 1998.
29. Tan EM, Cohen AS, Folstein JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7, 1982.
30. Ginabreda MGP, Yoshida CF, Niel C: Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz J Med Biol Res 30: 339-45, 1997.
31. Marchesoni A, Battafarano N, Podico M, Tosi S: Hepatitis C virus antibodies and systemic lupus erythematosus. Clin Exp Rheumatol 13: 267, 1995.
32. Martins RMB, Vanderborght BO, Rouzere C, Cardoso DD, Azevedo MS, Yoshida CF: Anti-HCV prevalence and risk factors analysis in pregnant women in central Brazil. Mem Inst Oswaldo Cruz 90: 11, 1995.
33. Martins RMB, Vanderborght BO, Rouzere CD, et al: Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of central Brazil. Rev Inst Med Trop São Paulo 36: 501-6, 1994.
34. Rosa H, Martins RMB, Vanderborght BOM: Association between leprosy and hepatitis C infection: a survey in a region of Central. Brazil. Am J Trop Med Hyg 55: 22-3, 1996.
35. Martins RMB, Almeida VC, Vanderborght BOM, et al: Prevalence of hepatitis C antibodies among health care workers at high risk for blood exposure. Rev Inst Med Trop São Paulo 38: 309-10, 1996.
36. Martins RMB, Vanderborght BO, Yoshida CF: Hepatitis C virus genotypes among blood donors from different regions of Brazil. Mem Inst Oswaldo Cruz 93: 299-300, 1998.
37. Barbosa AP, Martins RMB, Teles SA, Silva SA, Oliveira JM, Yoshida CF: Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz 97: 643-4, 2002.
38. Perlemuter G, Cacoub P, Sbai A, et al: Hepatitis C virus (HCV) infection and Systemic Lupus Erythematosus (SLE). Arthritis Rheum 43: S114, 2000.
39. Bruno S, Silini E, Crosignani A, et al: Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25: 754-8, 1997.
40. Trepo C: Genotype and viral load as prognostic indicators in the treatment of hepatitis C. J Viral Hepat 7: 250-7, 2000.
41. Fong TL, Valinluck B, Govindarajan S, et al: Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA level in chronic hepatitis C. Gastroenterology 107: 196-9, 1994.